Tempest Therapeutics share price logo

Tempest Therapeutics

NASDAQ: TPST

$0.50

-0.04

(-7.07%)

as on

Tempest Therapeutics Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.49
    $0.55
    downward going graph

    1.11%

    Downside

    11.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.50
    $5.46
    downward going graph

    -1.01%

    Downside

    1002.42%

    Upside

    downward going graph

Tempest Therapeutics share price movements today

Previous Close
$0.53
Open
$0.55
Volume
662.3K
Market Cap
$10.8M
Day's Low - High
$0.49 - $0.55
52 Week Low - High
$0.50 - $5.46

Tempest Therapeutics Historical Returns

1 Month Return
-36.09 %
3 Month Return
-38.27 %
1 Year Return
-89.86 %
3 Year Return
-97.89 %
5 Year Return
-99.3 %

Tempest Therapeutics Stock Fundamentals & Key Indicators

Check Tempest Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.8M

EPS (TTM)

-4.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.12

Industry PE ratio

-3.27

PEG Ratio

-0.00

EBITDA

-40.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-1270.11%

Tempest Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tempest Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Tempest Therapeutics image
Tempest Therapeutics
Buy$10.8M-99.30%-0.120.00%0.00%
Moderna image
Moderna
Neutral$85.5B-35.47%-26.84-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$134.2B192.00%30.5886.04%0.00%
Regeneron image
Regeneron
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Tempest Therapeutics Stock including INR - Dollar returns

The Tempest Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tempest Therapeutics investment value today

Current value as on today

₹10,076

Returns

-₹89,924

(-89.92%)

Returns from Tempest Therapeutics Stock

-₹90,580 (-90.58%)

Dollar Impact

₹656 (+0.66%)

Analyst Recommendation on Tempest Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Tempest Therapeutics. Average target price of $7

Tempest Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Tempest Therapeutics.

What analysts predicted

92.92%UPSIDE

Target Price

$7

Current Price

$0.4955

Analyzed by

1 Analysts

High

$7

Target

$7.00

Low

$7

Tempest Therapeutics target price $7, a slight upside of 92.92% compared to current price of $0.4955. According to 1 analysts rating.

Indian Investors' Interest in Tempest Therapeutics Stock

Search interest for Tempest Therapeutics Stock has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-88% versus previous 30 day period

Tempest Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
0
-
-
-22
-
Operating Income
-7
-9
-10
-13
-10
-7
-3
-4
-27
-5
EBITDA
-7
-9
-10
-13
-10
-7
-3
-3
-27
-5
Interest Expense
0
0
0
0
0
0
-
-
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-9
-10
-13
-10
-7
-3
-4
-27
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-7
-9
-10
-13
-10
-7
-3
-4
-27
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tempest Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
-1
0
-
-
-
0
-
Operating Income
-20
-23
-45
-19
-26
-34
-29
-42
-26
EBITDA
-84
-27
-43
-18
-26
-33
-27
-40
-25
Interest Expense
-
0
-
-
1
1
1
1
0
Depreciation
0
0
1
0
0
0
0
0
0
Income Before Tax
-84
-27
-44
-19
-28
-35
-29
-41
-26
Income Tax Expense
0
0
-
-
-
-
-
-
-
Net Income
-84
-27
-44
-19
-28
-35
-29
-41
-26
Net Profit Margin
90.51%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tempest Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-7
-9
-10
-13
-10
-7
-3
-4
-27
-5
Operating Cash Flow
-7
-5
-10
-10
-8
-8
-6
-3
-7
-2
Investing Cash Flow
0
0
0
0
-
-
-
-
-
-
Financing Cash Flow
0
4
1
17
0
1
0
3
1
1
Change in Cash
-6
-1
-8
7
-8
-7
-6
0
-5
-1

Tempest Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-84
-27
-44
-19
-28
-35
-29
-41
-26
Operating Cash Flow
-20
-23
-41
-19
-25
-31
-27
-33
-26
Investing Cash Flow
0
1
3
0
0
0
0
0
-
Financing Cash Flow
-4
78
26
34
59
11
35
24
4
Change in Cash
-26
55
-9
15
33
-20
8
-8
-22

Global Institutional Holdings in Tempest Therapeutics

Check out the Institutions with significant holdings in Tempest Therapeutics.

Funds
Holdings
Brad Bolzon
1.60%
VANGUARD INDEX FUNDS
1.38%
Vanguard
1.38%
Fidelity Concord Street Trust
0.42%

Tempest Therapeutics News & Key Events

  • img

    Today's Timeline - 15 September

    Wed, 01:40 AM

    -

    Tempest Therapeutics enters exclusive option agreement with Hebei Senlang for licensing CAR-T product candidates.

    Wed, 02:02 AM

    -

    Tempest Therapeutics raises $2.5 million through private placement of warrants and common stock.

Insights on Tempest Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 809.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 291.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, TPST stock has moved down by -36.1%

About Tempest Therapeutics

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.
OrganisationTempest Therapeutics
Headquarters2000 Sierra Point Parkway, Brisbane, CA, 94005, US
IndustryBiotechnology
CEOMatthew Angel

Key Management of Tempest Therapeutics

Name

Title

Dr. Matthew Angel Ph.D.

President, CEO & Director

Dr. Andrew Fang Ph.D.

Head of Business Development

FAQs

What is Tempest Therapeutics share price today?

Tempest Therapeutics share price today is $0.50 as on at the close of the market. Tempest Therapeutics share today touched a day high of $0.55 and a low of $0.49.

What is the 52 week high and 52 week low for Tempest Therapeutics share?

Tempest Therapeutics share touched a 52 week high of $5.46 on and a 52 week low of $0.50 on . Tempest Therapeutics stock price today i.e. is closed at $0.50,which is 90.93% down from its 52 week high and -1.00% up from its 52 week low.

What is Tempest Therapeutics's market capitalisation today?

Tempest Therapeutics market capitalisation is $0.00T as on .

How to invest in Tempest Therapeutics Stock (TPST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tempest Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Tempest Therapeutics Stock (TPST) from India?

Indian investors can start investing in Tempest Therapeutics (TPST) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Tempest Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Tempest Therapeutics share’s latest price of $0.50 as on October 31, 2026 at 8:46 am IST, you will get 20.1816 shares of Tempest Therapeutics. Learn more about fractional shares .

What are the returns that Tempest Therapeutics has given to Indian investors in the last 5 years?

Tempest Therapeutics stock has given -99.3% share price returns and 27.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?